FDTS Company Profile and Key Details

First Trust Developed Markets ex-US Small Cap AlphaDEX Fund last paid a dividend of 1.88 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Short-term trend indicators are bearishly aligned (SMA20 4.74%, SMA50 12.65%, SMA200 31.68%). The stock’s 14-day RSI is 78.13 (overbought), while the ATR of 0.92 points to moderate volatility. The stock remains hovering near 52-week lows, trading -1.36% below its high and over 92.83% above its low. Average 10-day trading volume of 1.59 thousand shares is significantly above the 3-month average of 961.19, indicating heightened recent market interest.

First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (NASDAQ:FDTS) closed at $70.44 USD, losing -$0.53 (-0.74%) from the previous close of $70.97. The stock is currently within 5% of its 52-week high $54.10 and $72.63. With a market capitalization of about $9.57 million, First Trust Developed Markets ex-US Small Cap AlphaDEX Fund is classified as a micro-cap and shows market-like volatility (beta ~1.02). Key stats such as the average daily volume over the past year has been around 845.00 shares, trading with heavier-than-usual volume. Headquartered in Wheaton, IL, First Trust Developed Markets ex-US Small Cap AlphaDEX Fund operates in the Financial Services sector and the Asset Management industry. Operating as an exchange-traded fund (ETF), the First Trust Developed Markets ex-US Small Cap AlphaDEX Fund endeavors to deliver investment performance that closely reflects the overall returns—both capital appreciation and income—of the Nasdaq AlphaDEX Developed Markets Ex-US Small Cap Index, prior to accounting for the fund's own operational costs and charges.

currently trading near 52-week highs band.

Our AI price prediction model suggests that First Trust Developed Markets ex-US Small Cap AlphaDEX Fund stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.